Sarepta Therapeutics stock trades at EUR 16.34 on Tuesday
Published on 11/03/2026 at 14:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- Sarepta's latest investor-relations releases cover upcoming investor conferences and third-quarter results.
- The company's next communications keep its rare-disease pipeline in focus for investors.
Sarepta Therapeutics stock traded at EUR 16.34 on Lang & Schwarz at 14:03 CET on Tuesday, November 3, 2026. The quote provides a current European trading reference for investors following the US rare-disease specialist.
Investor communications remain in focus
Sarepta's investor-relations page lists a release dated October 26, 2026, titled "Sarepta Therapeutics to Present at Upcoming Investor Conferences." A second release dated October 22 concerns the planned announcement of third-quarter 2026 financial results. The company has not yet published the results in the reviewed release list.
The announcements keep Sarepta's clinical and commercial development agenda in view ahead of its next corporate updates. For investors, the upcoming disclosures may provide fresh information on operating progress and the outlook for its rare-disease portfolio.
Investors can follow the real-time quote of Sarepta Therapeutics stock during the trading session.
Sarepta Therapeutics stock at a glance
- Company: Sarepta Therapeutics, Inc.
- ISIN: US8036071004
- Quote: EUR 16.34 on Lang & Schwarz
- Quote time: 14:03 CET, Tuesday, November 3, 2026
For corporate announcements, Sarepta refers investors to its official press-release page.
The S&P 500 provides the broader US market context for investors tracking Sarepta.
